![Elisabeth Whiting](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Elisabeth Whiting joined AnorMED in February 2001 and is responsible for the company's corporate strategic planning as well as all aspects of internal and external communications and investor relations.
Ms. Whiting has over 10 years of management experience in the biotechnology field including scientific research, financial and scientific communications and business development.
Prior to joining AnorMED, Ms. Whiting was Director, Investor Relations and Corporate Communications at Stressgen Biotechnologies Inc. Ms. Whiting holds a Masters of Science degree from the University of Ottawa.
Eerdere bekende functies van Elisabeth Whiting
| Bedrijven | Functie | Einde |
|---|---|---|
AnorMED, Inc.
 AnorMED, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops metal based therapeutics | Public Communications Contact | 09-11-2006 |
Opleiding van Elisabeth Whiting
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
13
Eerstegraads connecties
2
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
AnorMED, Inc.
AnorMED, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops metal based therapeutics | Health Technology |
University of Ottawa
 University of Ottawa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
